- Physician's Weekly

Lesion State Modulates Link Between sNfL & Age in Multiple Sclerosis

Apr 5, 2021

Prior research has shown that levels of serum neurofilament light (sNfL), a promising biomarker of...

Pediatric-Onset MS and Social Consequences

Apr 2, 2021

Pediatric-onset MS (PoMS) is associated with less educational achievement, lower earnings, and greater use of disability benefits throughout the working-age life span, according to a study published in JAMA Neurology....

Organoids; Warren vs Dinter Malpractice Case

Apr 1, 2021

[spreaker type=player resource=”episode_id=43421225″ theme=”light” autoplay=”false” playlist=”false” width=”100%” height=”200px”] Segments Organoids to help...

Vaccine Hesitancy; PBMT for COVID-19; Prevention of Gyn Cancer

Mar 31, 2021

[spreaker type=player resource=”episode_id=44175625″ theme=”light” autoplay=”false” playlist=”false” width=”100%” height=”200px”]

eBook: MONALEESA 7 confirms CDK4/6 inhibitor efficacy in younger women

Mar 30, 2021

[flippingbook width=”740px” height=”480px” title=”Trial Update – ASCO2020″]https://online.flippingbook.com/view/246895714/[/flippingbook]

MONALEESA 7 confirms CDK4/6 inhibitor efficacy in younger women

Mar 30, 2021

Ribociclib Claims First Ever Overall Survival Benefit for Targeted Therapy Adding the CDK4/6 inhibitor ribociclib to endocrine therapy significantly extended overall survival in younger women with advanced HR+/HER- breast cancer...

PW Podcast: The Manslaughter Case of a Long Island Doctor; Treating Obesity in Rural Practice; Grief and Covid-19

Mar 24, 2021

Episode Segments: FEATURE: Manslaughter Case of Long Island Doctor [Minute 18:06] In early March, a doctor was accused of writing prescriptions for ‘massive quantities of opioids,’ and was indicted on murder charges...

Depression Scores Change Significantly After Omalizumab Treatment for Urticaria

Mar 19, 2021

Chronic spontaneous urticaria (CSU) symptoms—such as recurrent hives, angioedema, itching, and...

Psychological Stress and Chronic Urticaria

Mar 19, 2021

Psychological Stress and Chronic Urticaria: A Neuro-immuno-cutaneous Crosstalk. A Systematic...

Chronic Urticaria in Children – New Insights from a Large Cohort

Mar 19, 2021

Chronic spontaneous urticaria is well-described in adults, but less so in children. The aim of...

MET Kinase Inhibitors Vs Sunitinib For pRCC

Mar 19, 2021

Sunitinib versus cabozantinib, crizotinib or savolitinib in metastatic papillary renal cell carcinoma (pRCC): Results from the randomized phase II SWOG 1500 study. MET signaling is a key molecular driver in papillary renal cell...

Follow-Up on Phase III JAVELIN Renal Trial: A+Ax vs S

Mar 19, 2021

Efficacy and safety of avelumab plus axitinib (A + Ax) versus sunitinib (S) in elderly patients with advanced renal cell carcinoma (aRCC): Extended follow-up results from JAVELIN Renal 101 In the phase III JAVELIN Renal 101...

Outcomes Of First-Line Immuno-Oncology Combo in mRCC

Mar 19, 2021

Outcomes of first-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC). Using the IMDC dataset, patients treated with a 1L...

Tivozanib In Patients With aRCC

Mar 19, 2021

TIVO-3: Tivozanib in patients with advanced renal cell carcinoma (aRCC) who have progressed after treatment with axitinib. The TIVO-3 study enrolled subjects with mRCC who failed two or three prior systemic regimens, one of...

Genitourinary Cancers Symposium: New therapy prolongs survival for patients with urothelial carcinoma

Mar 19, 2021

Enfortumab vedotin (EV) will likely become the new standard of care for treating patients with previously treated locally advanced or metastatic urothelial carcinoma (la/mUC). A recent phase 3 trial showed that treatment with...

Cabozantinib plus nivolumab provides better QoL than sunitinib

Mar 19, 2021

Although the CheckMate-9ER trial, comparing cabozantinib plus nivolumab to sunitinib in frontline metastatic renal cell carcinoma (mRCC), had recently demonstrated superiority in progression-free survival (PFS) and overall...